よむ、つかう、まなぶ。
【参考資料２－１】抗微生物薬適正使用の手引き 第四版（案）医科・外来編 (96 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
医科・外来編
100. Rosenfeld RM, et al. Natural history of untreated otitis media. Laryngoscope. 2003.
113(10):1645-57.
101. Jacobs J, et al. Homeopathic treatment of acute otitis media in children: a preliminary
randomized placebo-controlled trial. Pediatr Infect Dis J. 2001. 20(2):177-83.
102. Venekamp RP, et al. Antibiotics for acute otitis media in children. Cochrane Database Syst
Rev. 2015. (6):CD000219.
103. Casey JR, et al. New Patterns in the otopathogens causing acute otitis media six to eight
years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010.
29(4):304-9.
104. Shiro H, et al. Nationwide survey of the development of drug resistance in the pediatric field
in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of
Haemophilus influenzae and patients’ background factors. J Infect Chemother. 2015. 21:24756.
105. Hoberman A, et al. Shortened Antimicrobial Treatment for Acute Otitis Media in Young
Children. N Engl J Med. 2016. 375:2446-2456.
106. Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, Wallace A, Fang C, Singer J,
Suaya JA. Incidence of skin and soft tissue infections in ambulatory and inpatient settings,
2005-2010. BMC Infect Dis. 2015. 15:362.
107. Ohnishi T, Watanabe S, Matsumoto T, Yotsuyanagi H, Sato J, Kobayashi I, Iinuma S,
Nagayama T, Shibuya S, Ogawa N, Iozumi K, Nakajima Y, Kurikawa Y, Kobayashi M, Matsuo
K, Ishikawa H, Shimizu T, Tsutsui K, Kawamura T, Okuyama R, Seishima M, Akita Y, Kasugai
C, Yano K, Tamada Y, Mizutani K, Kabashima K, Yamada N, Ikeda M. The second
nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from
skin and soft-tissue infections in dermatology departments in Japan. J Infect Chemother.
2023. Erratum in: J Infect Chemother. 2023. 29(6):634-635.
108. Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC,
Berger M, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev.
2012. 1(1):CD003261.
109. Cross ELA, Jordan H, Godfrey R, Onakpoya IJ, Shears A, Fidler K, Peto TEA, Walker AS,
Llewelyn MJ. Route and duration of antibiotic therapy in acute cellulitis: A systematic review
and meta-analysis of the effectiveness and harms of antibiotic treatment. J Infect. 2020.
81(4):521-531.
110. Pallin DJ, Binder WD, Allen MB, Lederman M, Parmar S, Filbin MR, Hooper DC, Camargo
CA Jr. Clinical trial: comparative effectiveness of cephalexin plus trimethoprimsulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a
randomized controlled trial. Clin Infect Dis. 2013. 56(12):1754-62.
111. Nardi NM, Schaefer TJ. Impetigo. Treasure Island, FL: StatPearls Publishing; 2021.
112. Gottlieb M, DeMott JM, Hallock M, Peksa GD. Systemic Antibiotics for the Treatment of Skin
and Soft Tissue Abscesses: A Systematic Review and Meta-Analysis. Ann Emerg Med.
2019. 73(1):8-16.
96
第四版
医科・外来編
100. Rosenfeld RM, et al. Natural history of untreated otitis media. Laryngoscope. 2003.
113(10):1645-57.
101. Jacobs J, et al. Homeopathic treatment of acute otitis media in children: a preliminary
randomized placebo-controlled trial. Pediatr Infect Dis J. 2001. 20(2):177-83.
102. Venekamp RP, et al. Antibiotics for acute otitis media in children. Cochrane Database Syst
Rev. 2015. (6):CD000219.
103. Casey JR, et al. New Patterns in the otopathogens causing acute otitis media six to eight
years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010.
29(4):304-9.
104. Shiro H, et al. Nationwide survey of the development of drug resistance in the pediatric field
in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of
Haemophilus influenzae and patients’ background factors. J Infect Chemother. 2015. 21:24756.
105. Hoberman A, et al. Shortened Antimicrobial Treatment for Acute Otitis Media in Young
Children. N Engl J Med. 2016. 375:2446-2456.
106. Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, Wallace A, Fang C, Singer J,
Suaya JA. Incidence of skin and soft tissue infections in ambulatory and inpatient settings,
2005-2010. BMC Infect Dis. 2015. 15:362.
107. Ohnishi T, Watanabe S, Matsumoto T, Yotsuyanagi H, Sato J, Kobayashi I, Iinuma S,
Nagayama T, Shibuya S, Ogawa N, Iozumi K, Nakajima Y, Kurikawa Y, Kobayashi M, Matsuo
K, Ishikawa H, Shimizu T, Tsutsui K, Kawamura T, Okuyama R, Seishima M, Akita Y, Kasugai
C, Yano K, Tamada Y, Mizutani K, Kabashima K, Yamada N, Ikeda M. The second
nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from
skin and soft-tissue infections in dermatology departments in Japan. J Infect Chemother.
2023. Erratum in: J Infect Chemother. 2023. 29(6):634-635.
108. Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC,
Berger M, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev.
2012. 1(1):CD003261.
109. Cross ELA, Jordan H, Godfrey R, Onakpoya IJ, Shears A, Fidler K, Peto TEA, Walker AS,
Llewelyn MJ. Route and duration of antibiotic therapy in acute cellulitis: A systematic review
and meta-analysis of the effectiveness and harms of antibiotic treatment. J Infect. 2020.
81(4):521-531.
110. Pallin DJ, Binder WD, Allen MB, Lederman M, Parmar S, Filbin MR, Hooper DC, Camargo
CA Jr. Clinical trial: comparative effectiveness of cephalexin plus trimethoprimsulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a
randomized controlled trial. Clin Infect Dis. 2013. 56(12):1754-62.
111. Nardi NM, Schaefer TJ. Impetigo. Treasure Island, FL: StatPearls Publishing; 2021.
112. Gottlieb M, DeMott JM, Hallock M, Peksa GD. Systemic Antibiotics for the Treatment of Skin
and Soft Tissue Abscesses: A Systematic Review and Meta-Analysis. Ann Emerg Med.
2019. 73(1):8-16.
96